New York State Practitioner Education - Medical Use of Marijuana Course
You are not logged in. Only partial content from this topic will be available to you. To view the full content, you must log in to your account. Don't have a login? Register now. Or, check out our Preview.

Syllabus Topic I: The Endocannabinoid System and Phytocannabinoids


The Endocannabinoid System (ECS):

 

In order to fully appreciate the rationale for the clinical use of medical cannabis, it is essential that one has knowledge of the endocannabinoid system, an endogenous regulating system found in all vertebrates (1, 2).  It is also important to understand the clinical sequelae that might develop as a result of endocannabinoid system dysfunction.

 

It has been proposed that a properly functioning endogenous cannabinoid system is essential for good health and that certain disease types may be the result of deficiencies within this system (3).   “Modulating the activity of the endocannabinoid system … hold[s] therapeutic promise in a wide range of disparate diseases and pathological conditions, ranging from mood and anxiety disorders, movement disorders such as Parkinson’s and Huntington’s disease, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome and osteoporosis, to name just a few (4)."  In this introductory section, we will discuss the endocannabinoid system and phytocannabinoids.

 

For more information, please review The Medical Use of Marijuana Course Table of Contents.



Take a quiz or play a crossword related to this syllabus topic.

This syllabus content additionally qualifies for the following CME designations: Medical Marijuana, Pain Medicine, Palliative Care